BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35311629)

  • 21. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas.
    Hsiao YW; Chiu LT; Chen CH; Shih WL; Lu TP
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31434354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 23. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
    Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
    BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RIPK3 mRNA level acts as a diagnostic biomarker in hepatitis B virus-associated hepatocellular carcinoma.
    Han LY; Yang JR; Zhao ZH; Gao S; Fan YC; Wang K
    Pathol Res Pract; 2020 Oct; 216(10):153147. PubMed ID: 32853963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
    Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
    J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma.
    Kong F; Kong D; Yang X; Yuan D; Zhang N; Hua X; You H; Zheng K; Tang R
    Cancer Med; 2020 Apr; 9(7):2462-2479. PubMed ID: 32017470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
    Yu SJ; Kim YJ
    World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
    Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
    Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus‑associated hepatocellular carcinoma.
    Wang X; Huang K; Zeng X; Liu Z; Liao X; Yang C; Yu T; Han C; Zhu G; Qin W; Peng T
    Oncol Rep; 2019 May; 41(5):2855-2875. PubMed ID: 30896816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
    Fang Q; Chen H
    Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
    Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
    PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
    Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
    Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
    Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
    Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Chen S; Dong Z; Yang P; Wang X; Jin G; Yu H; Chen L; Li L; Tang L; Bai S; Yan H; Shen F; Cong W; Wen W; Wang H
    Cancer Lett; 2017 May; 394():22-32. PubMed ID: 28216372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.